A CEO is often scapegoat for decisions he wasn't making on his own. Arguably he worst thing about the collective weakness of management is the time they've wasted. For example, does anyone have a feel for the impact of developments like
"Quiet Therapeutics focuses on drug delivery using nanoparticles known as gagomers. These wrap lipid particles in hyaluronic acid, a glycosaminoglycan (GAG) that naturally targets cancer and inflammation"
on the immediate or longer-term value of ACL oncology IP?
A CEO is often scapegoat for decisions he wasn't making on his...
Add to My Watchlist
What is My Watchlist?
 (20min delay)
|
|||||
|
Last
1.0¢ |
Change
0.000(0.00%) |
Mkt cap ! $1.409M | |||
| Open | High | Low | Value | Volume |
| 0.0¢ | 0.0¢ | 0.0¢ | $0 | 0 |
| TSN (ASX) Chart |
Day chart unavailable